What is the recommended dose of epinephrine (adrenaline) for anaphylaxis, cardiac arrest, and hypotension according to Canadian guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Anaphylaxis, Cardiac Arrest, and Hypotension

Anaphylaxis (First-Line Treatment)

For anaphylaxis, administer 0.3 to 0.5 mg of epinephrine (1:1000 concentration) intramuscularly into the anterolateral thigh in adults, repeated every 5 to 15 minutes as needed. 1, 2

Intramuscular Dosing (Preferred Route)

  • Adults and children ≥30 kg: 0.3 to 0.5 mg (0.3 to 0.5 mL of 1:1000) IM into anterolateral thigh 1, 3
  • Children <30 kg: 0.01 mg/kg (0.01 mL/kg of 1:1000), maximum 0.3 mg IM into anterolateral thigh 1, 3
  • Repeat dosing: Every 5 to 15 minutes as needed based on clinical response 1, 2
  • The intramuscular route in the lateral thigh produces rapid peak plasma concentrations (8 ± 2 minutes) compared to subcutaneous injection (34 ± 14 minutes) 4

Autoinjector Dosing (Community Settings)

  • 0.15 mg autoinjector: For patients weighing 7.5 to 25 kg (16.5 to 55 lbs) 1
  • 0.3 mg autoinjector: For patients weighing ≥25 kg (≥55 lbs) 1

Intravenous Epinephrine for Anaphylactic Shock

When IV access is already established and the patient has anaphylactic shock, administer 0.05 to 0.1 mg (50 to 100 mcg) of epinephrine (1:10,000 concentration) as a slow IV bolus. 1

  • IV bolus dose: 0.05 to 0.1 mg (0.5 to 1 mL of 1:10,000) given slowly 1
  • This represents 5% to 10% of the cardiac arrest dose 1
  • Pediatric IV dose: 0.01 mg/kg (0.1 mL/kg of 1:10,000; maximum 0.3 mg) given slowly over several minutes with continuous hemodynamic monitoring 4

Epinephrine Infusion for Refractory Anaphylaxis

For persistent hypotension or when more than three boluses have been administered, initiate an epinephrine infusion at 5 to 15 mcg/min (0.05 to 0.1 mcg/kg/min in children). 1, 4

  • Adult infusion: 5 to 15 mcg/min, titrated to blood pressure and clinical response 1
  • Pediatric infusion: 0.05 to 0.1 mcg/kg/min (1-4 mcg/min), using 1 mg epinephrine in 250 mL D5W (4 mcg/mL concentration) 4
  • Continuous hemodynamic monitoring is mandatory during IV administration 4

Cardiac Arrest

In cardiac arrest (including anaphylaxis-induced arrest), administer standard ACLS epinephrine dosing: 1 mg IV/IO every 3 to 5 minutes. 1

Standard Cardiac Arrest Dosing

  • Adult dose: 1 mg (1 mL of 1:1000 or 10 mL of 1:10,000) IV/IO every 3 to 5 minutes 1
  • Pediatric dose: 0.01 mg/kg (0.1 mL/kg of 1:10,000; maximum single dose 1 mg) IV/IO every 3 to 5 minutes 4
  • Standard BLS and ACLS protocols take priority in anaphylaxis-induced cardiac arrest 1

Hypotension Management

Refractory Hypotension Despite Epinephrine

For hypotension refractory to epinephrine and fluid resuscitation, add norepinephrine infusion at 0.05 to 0.5 mcg/kg/min. 4

  • Norepinephrine infusion: 0.05 to 0.5 mcg/kg/min for persistent hypotension 4
  • Vasopressin: Consider 1 to 2 IU bolus with or without infusion (2 units/h) for refractory hypotension 4
  • Dopamine (pediatric): 2 to 20 mcg/kg/min titrated to maintain systolic BP >90 mmHg 4

Special Population: Beta-Blocker Patients

Patients on beta-blockers with refractory symptoms require IV glucagon 1 to 2 mg (pediatric: 20-30 mcg/kg, maximum 1 mg) over 5 minutes. 4


Critical Pitfalls to Avoid

  • Never delay epinephrine administration — delayed injection is associated with fatalities 4, 5, 6
  • Never substitute antihistamines or corticosteroids for epinephrine as first-line treatment 1, 4
  • Do not confuse anaphylaxis dosing with cardiac arrest dosing — this iatrogenic error can cause lethal cardiac complications from inappropriate IV push of 1 mg doses 7, 8
  • Avoid subcutaneous administration — it has delayed onset compared to intramuscular injection 4, 5
  • Do not inject into buttocks, digits, hands, or feet — risk of tissue necrosis and inadequate absorption 3
  • Ensure continuous monitoring when using IV epinephrine — risk of arrhythmias and hypertensive crisis 4, 3

Post-Treatment Monitoring

  • Observe for minimum 6 hours in a monitored setting until stable and symptoms regressing 4
  • Obtain mast cell tryptase levels at 1 hour, 2-4 hours, and baseline (>24 hours post-reaction) 4
  • Prescribe epinephrine autoinjector before discharge with written emergency action plan 4, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.